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To the Editor: 
Cornelia de Lange syndrome (CdLS, OMIM #122470) is a multiple congenital 
anomaly syndrome characterized by dysmorphic facial features, hirsutism, severe 
growth and developmental delay, and malformed upper limbs [Jackson et al., 1993; 
Ireland et al., 1993].  The prevalence is estimated to be 1/10,000 [Opitz, 1985].  
Recently, two independent groups proved that CdLS is caused by NIPBL mutations 
[Tonkin et al., 2004; Krantz et al., 2004].  NIPBL consists of 47 exons and encodes 
delangin, a 2,804 amino-acid protein, from exon 2 to 47.   
We analyzed 15 Japanese sporadic patients (CdL 1-15) with typical CdLS 
features (Table I) and their parents after obtaining written informed consent.  All 
protocols in this study were approved by the Committee for the Ethical Issues on 
Human Genome and Gene analysis, Nagasaki University.  Clinical geneticists 
diagnosed these patients based on mental and growth retardation, and characteristic 
facial features.  Genomic DNA was extracted using a standard protocol.  Fourty-six 
coding exons (from exon 2 to 47) of NIPBL were amplified by PCR as described 
previously [Krantz et al., 2004] except for exons 4, 33, 37 and 41, of which primers 
were originally designed (available on request).  Sequence analysis was performed as 
described previously [Kurotaki et al. 2003]. 
We identified three novel nonsense mutations and one missense mutation in 
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NIPBL among the 15 Japanese patients examined: 1885C>T (R629X) (CdL 4) and 
1921G>T (E641X) (CdL 2) in exon 10, 3346G>T (E1116X) (CdL 15) in exon 12 and 
5483G>A (R1828Q) (CdL 10) in exon 29.  All the four mutations were not found in 
any of 97 normal Japanese controls or in the JSNP database 
(http://snp.ims.u-tokyo.ac.jp/).  The altered amino acid (R1828Q) was de novo and 
located in the evolutionally conserved sequences at least in the human, rat, mouse and 
fly homologs, thus the change is likely to be pathological.   
The C-terminal half ~1500 amino acids of delangin is well conserved among 
homologs of flies, worms, plants, and fungi, and is expected to be biologically 
important [Tonkin et al., 2004], though it was not found to contain any obvious 
functional domains by analysis using PROSITE 
(http://kr.expasy.org/cgi-bin/prosite/PSScan.cgi).  Three protein truncation mutations at 
amino acid positions 629, 641 and 1116 and a missense mutation at amino acid position 
1828 could lose or impair the C-terminal half function.  The Drosophila homolog of 
NIPBL, Nipped-B, is involved in activating the Ubx and Cut homeobox genes.  Ubx 
suppresses the limb formation by repressing Dll that requires for the distal limb 
development, and Cut mutations cause leg and wing abnormalities [Tonkin et al., 2004].  
Thus, it is plausible that reduced expression of human NIPBL may lead to limb 
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anomalies in CdLS.   
Interestingly, limb abnormalities (oligodactyly and ulner deficiency) were 
observed in 3 of our 4 patients with a mutation, but only one of 7 patients without any 
mutation whose clinical information was available did show some limb abnormality 
(oligodactyly), though Gillis et al. [2004] reported that severity of limb defects was not 
statistically different between mutation-positive and mutation-negative patients.   
Additionally, three single nucleotide polymorphisms (SNPs), 1151A>G 
(N384S) in exon 9, 2021A>G (N674S) in exon 10 and 5874T>C (S1958S) in exon 33, 
were identified, as they were found among normal controls and the second substitution 
(2021A>G) was previously reported as a SNP [Gillis et al., 2004].  Allele frequencies 
of the three SNPs in normal Japanese controls are 3.2 % (6/186), 13.0 % (25/192) and 
64.5 % (129/200), respectively.  
To exclude a submicroscopic deletion around NIPBL and its franking regions, 
fluorescence in situ hybridization (FISH) analysis was performed in 10 of 15 cases on 
their metaphase chromosomes using 2 BAC clones covering the NIPBL gene (Table I), 
RP11-14I21 and RP11-7M4, selected from the UCSC genome browser, 2003 July 
version (http://genome.ucsc.edu/cgi-bin/hgGateway).  FISH and subsequent 
photomicroscopy were performed as described previously [Miyake et al., 2004].    
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However none of them showed any deletion. 
We also investigated core promoter regions in 11 affected individuals not 
having detectable point mutations in the coding regions.  Two core promoter regions 
were identified, raging -800 to -500bp (CPR-A) and -400 to +200bp (CPR-B) from the 
beginning of NIPBL cDNA (NM_015384.3) using four different promoter prediction 
programs: neural network promoter prediction program 
(http://www.fruitfly.org/seq_tools/promoter.html), human core-promoter finder 
(http://rulai.cshl.org/tools/genefinder/CPROMOTER/human.htm), promoter 2.0 
prediction server (http://www.cbs.dtu.dk/services/promoter/), bioinformatics & 
molecular analysis section (http://bimas.dcrt.nih.gov/molbio/proscan/).  No nucleotide 
changes were detected among the 11 patients in the two core promoter regions except 
for a part of CPR-B sequence (-60~+60) which was hardly determined due to high GC 
ratio (75.83 %), suggesting that promoter mutations in NIBPL is less likely. 
In conclusion, we identified four novel NIPBL mutations and three SNPs.  It 
is important to describe a full spectrum of phenotype in more patients with positive 




We thank patients and their families for their participation in this study, and Dr. 
Krantz for kindly giving us information of primers.  We also express our gratitude to 
Yasuko Noguchi, Naoko Yanai and Kazumi Miyazaki for their excellent technical 
assistance.  This study was supported by grants from CREST, Japan Science and 











Gillis LA, McCallum J, Kaur M, DeScipio C, Yaeger D, Mariani A, Kline AD, Li HH, 
Devoto M, Jackson LG, Krantz ID. 2004. NIPBL Mutational Analysis in 120 
Individuals with Cornelia de Lange Syndrome and Evaluation of 
Genotype-Phenotype Correlations. Am J Hum Genet 75(4):610-623 
Ireland M, Donnai D, Burn J. 1993. Brachmann-de Lange syndrome. Delineation of the 
clinical phenotype. Am J Med Genet 47(7):959-964. 
Jackson L, Kline AD, Barr MA, Koch S. 1993. de Lange syndrome: a clinical review of 
310 individuals. Am J Med Genet 47(7):940-946. 
Krantz ID, McCallum J, DeScipio C, Kaur M, Gillis LA, Yaeger D, Jukofsky L, 
Wasserman N, Bottani A, Morris CA, Nowaczyk MJ, Toriello H, Bamshad MJ, 
Carey JC, Rappaport E, Kawauchi S, Lander AD, Calof AL, Li HH, Devoto M, 
Jackson LG. 2004. Cornelia de Lange syndrome is caused by mutations in 
NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet 
36(6):631-635. 
Kurotaki N, Harada N, Shimokawa O, Miyake N, Kawame H, Uetake K, Makita Y, 
Kondoh T, Ogata T, Hasegawa T, Nagai T, Ozaki T, Touyama M, Shenhav R, 
Ohashi H, Mende L, Shiihara T, Ohtsu S, Kato Z, Okamoto N, Nishimoto J, Lev 
 8
D, Miyoshi Y, Ishikiriyama S, Sonoda T, Sakazume S, Fukushima Y, Kurosawa 
K, Cheng FJ, Yoshiura K, Ohta T, Kishino T, Niikawa N, Matsumoto N. 2003. 
Fifty microdeletions among 112 cases of Sotos syndrome: low copy repeats 
possibly mediate the common deletion. Hum Mutat 22(5):378-387. 
Miyake N, Tonoki H, Gallego M, Harada N, Shimokawa O, Yoshiura KI, Ohta T, 
Kishino T, Niikawa N, Matsumoto N. 2004. Phenotype-genotype correlation in 
two patients with 12q proximal deletion. J Hum Genet.49(5):282-284 
Opitz JM. 1985. The Brachmann-de Lange syndrome. Am J Med Genet 22(1):89-102. 
Tonkin ET, Wang TJ, Lisgo S, Bamshad MJ, Strachan T. 2004. NIPBL, encoding a 
homolog of fungal Scc2-type sister chromatid cohesion proteins and fly 
Nipped-B, is mutated in Cornelia de Lange syndrome. Nat Genet 36(6):636-641. 
 
